{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:59:46Z","timestamp":1765040386120},"reference-count":35,"publisher":"Cambridge University Press (CUP)","issue":"8","license":[{"start":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T00:00:00Z","timestamp":1420156800000},"content-version":"unspecified","delay-in-days":884,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:sec id=\"S0195941700031301_abs1\"><jats:title>Background.<\/jats:title><jats:p>Methicillin-resistant<jats:italic>Staphylococcus aureus<\/jats:italic>(MRSA) pulsed-field type (PFT) USA300 causes skin and soft tissue infections in military recruits and invasive disease in hospitals. Chlorhexidine gluconate (CHG) is used to reduce MRSA colonization and infection. The impact of CHG on the molecular epidemiology of MRSA is not known.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700031301_abs2\"><jats:title>Objective.<\/jats:title><jats:p>To evaluate the impact of 2% CHG\u2014impregnated cloths on the molecular epidemiology of MRSA colonization.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700031301_abs3\"><jats:title>Design.<\/jats:title><jats:p>Cluster-randomized, double-blind, controlled trial.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700031301_abs4\"><jats:title>Setting.<\/jats:title><jats:p>Marine Officer Candidate School, Quantico, Virginia, in 2007.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700031301_abs5\"><jats:title>Participants.<\/jats:title><jats:p>Military recruits.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700031301_abs6\"><jats:title>Intervention.<\/jats:title><jats:p>Thrice-weekly application of CHG-impregnated or control (Comfort Bath; Sage) cloths over the entire body.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700031301_abs7\"><jats:title>Measurements.<\/jats:title><jats:p>Baseline and serial (every 2 weeks) nasal and\/or axillary swab samples were assessed for MRSA colonization. Molecular analysis was performed with pulsed-field gel electrophoresis.<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700031301_abs8\"><jats:title>Results.<\/jats:title><jats:p>During training, 77 subjects (4.9%) acquired MRSA, 26 (3.3%) in the CHG group and 51 (6.5%) in the control group (<jats:italic>P<\/jats:italic>= .004). When analyzed for PFT, 24 subjects (3.1%) in the control group but only 6 subjects (0.8%) in the CHG group (<jats:italic>P<\/jats:italic>= .001) had USA300. Of the 167 colonizing isolates recovered from 77 subjects, 99 were recovered from the control group, including USA300 (40.4%), USA800 (38.4%), USA1000 (12.1%), and USA100 (6.1%), and 68 were recovered from the CHG group, including USA800 (51.5%), USA100 (23.5%), and USA300 (13.2%).<\/jats:p><\/jats:sec><jats:sec id=\"S0195941700031301_abs9\"><jats:title>Conclusions.<\/jats:title><jats:p>CHG decreased the transmission of MRSA\u2014more specifically, USA300\u2014among military recruits. In addition, USA300 and USA800 outcompeted other MRSA PFTs at incident colonization. Future studies should evaluate the broad-based use of CHG to decrease transmission of USA300 in hospital settings.<\/jats:p><\/jats:sec>","DOI":"10.1086\/666631","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T16:49:39Z","timestamp":1341334179000},"page":"809-816","source":"Crossref","is-referenced-by-count":19,"title":["Chlorhexidine Gluconate Reduces Transmission of Methicillin-Resistant<i>Staphylococcus aureus<\/i>USA300 among Marine Recruits"],"prefix":"10.1017","volume":"33","author":[{"given":"Timothy J.","family":"Whitman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carey D.","family":"Schlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg A.","family":"Grandits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene V.","family":"Millar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Mende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane R.","family":"Hospenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick R.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Tribble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2015,1,2]]},"reference":[{"key":"S0195941700031301_ref033","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.45902-0"},{"key":"S0195941700031301_ref028","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.19.2073"},{"key":"S0195941700031301_ref035","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02836.x"},{"key":"S0195941700031301_ref010","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-5-200603070-00005"},{"key":"S0195941700031301_ref005","doi-asserted-by":"publisher","DOI":"10.1086\/657136"},{"key":"S0195941700031301_ref006","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.11.5113-5120.2003"},{"key":"S0195941700031301_ref013","first-page":"384","volume-title":"Manual of Clinical Microbiology","author":"Bannerman","year":"2003"},{"key":"S0195941700031301_ref015","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2009.02.013"},{"key":"S0195941700031301_ref012","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05804-11"},{"key":"S0195941700031301_ref014","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/JCM.33.9.2233-2239.1995","article-title":"Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing","volume":"33","author":"Tenover","year":"1995","journal-title":"J Clin Microbiol"},{"key":"S0195941700031301_ref008","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00480-08"},{"key":"S0195941700031301_ref030","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31819ffe6d"},{"key":"S0195941700031301_ref018","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1999.tb13475.x"},{"key":"S0195941700031301_ref020","doi-asserted-by":"publisher","DOI":"10.1086\/528716"},{"key":"S0195941700031301_ref001","doi-asserted-by":"publisher","DOI":"10.1086\/423965"},{"key":"S0195941700031301_ref002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043252"},{"key":"S0195941700031301_ref003","doi-asserted-by":"publisher","DOI":"10.1086\/428573"},{"key":"S0195941700031301_ref007","doi-asserted-by":"publisher","DOI":"10.1086\/533494"},{"key":"S0195941700031301_ref009","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00511-07"},{"key":"S0195941700031301_ref027","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/524736","article-title":"Chlorhexidine: expanding the armamentarium for infection control and prevention","volume":"46","author":"Milstone","year":"2008","journal-title":"Clin Infect Dis"},{"key":"S0195941700031301_ref011","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02352-08"},{"key":"S0195941700031301_ref016","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard; Seventh Edition","year":"2006"},{"key":"S0195941700031301_ref017","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.10.1997"},{"key":"S0195941700031301_ref024","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2008.05.002"},{"key":"S0195941700031301_ref019","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2813"},{"key":"S0195941700031301_ref021","doi-asserted-by":"publisher","DOI":"10.1086\/499815"},{"key":"S0195941700031301_ref022","doi-asserted-by":"publisher","DOI":"10.1086\/595844"},{"key":"S0195941700031301_ref023","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.09.79"},{"key":"S0195941700031301_ref025","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2008.09.012"},{"key":"S0195941700031301_ref026","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055356"},{"key":"S0195941700031301_ref029","doi-asserted-by":"publisher","DOI":"10.1086\/605925"},{"key":"S0195941700031301_ref031","doi-asserted-by":"publisher","DOI":"10.1086\/519929"},{"key":"S0195941700031301_ref032","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn208"},{"key":"S0195941700031301_ref034","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2010.93"},{"key":"S0195941700031301_ref004","unstructured":"Gorwitz RJ , Jernigan DB , Powers JH , Jernigan JA , Participants in the CDC Convened Experts' Meeting on Management of MRSA in the Community. Strategies for Clinical Management of MRSA in the Community: Summary of an Experts' Meeting Convened by the Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 2006. http:\/\/www.cdc.gov\/ncidod\/dhqp\/ar_mrsa_ca.html."}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0195941700031301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T06:19:06Z","timestamp":1594361946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0195941700031301\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0195941700031301"],"URL":"https:\/\/doi.org\/10.1086\/666631","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}